104 related articles for article (PubMed ID: 30866090)
1. MicroRNAs as markers to monitor endothelin-1 signalling and potential treatment in renal disease: Carcinoma - proteinuric damage - toxicity.
Fries JWU
Biol Cell; 2019 Jul; 111(7):169-186. PubMed ID: 30866090
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.
von Brandenstein M; Pandarakalam JJ; Kroon L; Loeser H; Herden J; Braun G; Wendland K; Dienes HP; Engelmann U; Fries JW
Am J Pathol; 2012 May; 180(5):1787-97. PubMed ID: 22429968
[TBL] [Abstract][Full Text] [Related]
3. ET-1 Induced Downregulation of MRP2 via miRNA 133a - A Marker for Tubular Nephrotoxicity?
Loeser H; von Brandenstein M; Herschung A; Schlosser M; Büttner R; Fries JW
Am J Nephrol; 2015; 41(3):191-9. PubMed ID: 25871823
[TBL] [Abstract][Full Text] [Related]
4. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer.
Oto J; Plana E; Sánchez-González JV; García-Olaverri J; Fernández-Pardo Á; España F; Martínez-Sarmiento M; Vera-Donoso CD; Navarro S; Medina P
Curr Urol Rep; 2020 Mar; 21(2):11. PubMed ID: 32166474
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as Urinary Biomarker for Oncocytoma.
von Brandenstein M; Schlosser M; Herden J; Heidenreich A; Störkel S; Fries JWU
Dis Markers; 2018; 2018():6979073. PubMed ID: 30116406
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
Kanki M; Moriguchi A; Sasaki D; Mitori H; Yamada A; Unami A; Miyamae Y
Toxicology; 2014 Oct; 324():158-68. PubMed ID: 24863737
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive urine markers for the differentiation between RCCs and oncocytoma.
von Brandenstein M; Herden J; Köditz B; Huerta M; Nestler T; Heidenreich A; Fries JWU
J Clin Lab Anal; 2021 May; 35(5):e23762. PubMed ID: 33960011
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 induces NF-kappaB via two independent pathways in human renal tubular epithelial cells.
Gerstung M; Roth T; Dienes HP; Licht C; Fries JW
Am J Nephrol; 2007; 27(3):294-300. PubMed ID: 17460393
[TBL] [Abstract][Full Text] [Related]
10. ETS-dependent p16INK4a and p21waf1/cip1 gene expression upon endothelin-1 stimulation in malignant versus and non-malignant proximal tubule cells.
von Brandenstein M; Schlosser M; Richter C; Depping R; Fries JW
Life Sci; 2012 Oct; 91(13-14):562-71. PubMed ID: 22521293
[TBL] [Abstract][Full Text] [Related]
11. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
[TBL] [Abstract][Full Text] [Related]
12. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma.
Cochetti G; Cari L; Nocentini G; Maulà V; Suvieri C; Cagnani R; Rossi De Vermandois JA; Mearini E
Sci Rep; 2020 Dec; 10(1):21290. PubMed ID: 33277569
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
Zoja C; Liu XH; Abbate M; Corna D; Schiffrin EL; Remuzzi G; Benigni A
Exp Nephrol; 1998; 6(2):121-31. PubMed ID: 9567218
[TBL] [Abstract][Full Text] [Related]
14. Endothelin antagonists and renal protection.
Benigni A; Perico N; Remuzzi G
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
[TBL] [Abstract][Full Text] [Related]
15. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1.
Gómez-Garre D; Largo R; Tejera N; Fortes J; Manzarbeitia F; Egido J
Hypertension; 2001 Apr; 37(4):1171-8. PubMed ID: 11304520
[TBL] [Abstract][Full Text] [Related]
16. Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury.
Pavkovic M; Riefke B; Ellinger-Ziegelbauer H
Toxicology; 2014 Oct; 324():147-57. PubMed ID: 24880025
[TBL] [Abstract][Full Text] [Related]
17. Mouse population-based evaluation of urinary protein and miRNA biomarker performance associated with cisplatin renal injury.
Harrill AH; Lin H; Tobacyk J; Seely JC
Exp Biol Med (Maywood); 2018 Feb; 243(3):237-247. PubMed ID: 29110506
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis and urinary biomarker assays reveal activation of tubulointerstitial injury pathways in a rodent model of chronic proteinuria (Doxorubicin nephropathy).
Cianciolo R; Yoon L; Krull D; Stokes A; Rodriguez A; Jordan H; Cooper D; Falls JG; Cullen J; Kimbrough C; Berridge B
Nephron Exp Nephrol; 2013; 124(1-2):1-10. PubMed ID: 24248038
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria.
Vlachojannis JG; Tsakas S; Petropoulou C; Goumenos DS; Alexandri S
Clin Nephrol; 2002 Nov; 58(5):337-43. PubMed ID: 12425483
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
